OmerMujahidAliMD

PubMed

• 18 citations
  Treatment of CD19-positive mixed phenotype acute leukemia with blinatumomab.
  Firas El Chaer, Omer Ali, Edward A. Sausville, Jennie Y. Law, Seung Tae Lee
  American Journal of Hematology. 2019-01-01
• 3 citations
  Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting.
  Akshat M Patel, Omer Ali, Radhika Kainthla, Syed M Rizvi, Farrukh T Awan
  Neuro-Oncology Practice. 2022-05-01
• 5 citations
  Peripheral blood blast rate of clearance is an independent predictor of clinical response and outcomes in acute myeloid leukaemia.
  Noa G. Holtzman, Firas El Chaer, Maria R. Baer, Omer Ali, Ameet Patel
  British Journal of Haematology. 2020-03-01

Journal Articles

• Primary central nervous system lymphoma: a real-world comparison of therapy access and outcomes by hospital setting  
  Akshat M Patel, Omer Ali, Radhika Kainthla, Syed M Rizvi, Farrukh T Awan, Toral Patel, Edward Pan, Elizabeth Maher, Neil B Desai, Robert Timmerman, Kiran A Kumar, Prav..., Neuro-Oncology Practice, 1/12/2022

Abstracts/Posters

• A Radiomic Machine Learning Model to Predict Treatment Response to Methotrexate and Survival Outcomes in Primary Central Nervous System Lymphoma (PCNSL)
  Omer M Ali, MD, Sahil S Nalawade, MS, Yin Xi, PhD, Ben Wagner, BM, Alexander Mazal, MD, Shane Ahlers, MD, Syed M Rizvi, MD, Farrukh T Awan, MD, Kiran A Kumar, MD, MBA,..., American Society of Hematology 2020, 12/6/2020